Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months
Matthew F. Daley(Kaiser Permanente), Frank DeStefano(Abbott Fund), Darios Getahun(Kaiser Permanente), David L. McClure(Marshfield Clinic), Nicola P. Klein, Jonathan Duffy(Centers for Disease Control and Prevention), Stephanie A. Irving(Kaiser Permanente Center for Health Research), James D. Nordin(HealthPartners), Simon J. Hambidge, Liza M. Reifler(Kaiser Permanente), Satoshi Kamidani(Emory University), Michael L. Jackson(Kaiser Permanente Washington Health Research Institute), Jason M. Glanz(Kaiser Permanente)
Cited by 24
Related Papers
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381
Risk of Anaphylaxis After Vaccination of Children and Adolescents
|PEDIATRICS|2003|321